1-2 of 2
Xu-Liang Shen
Close
Sort by
Journal Articles

Pomalidomide, bortezomib, and dexamethasone for newly diagnosed multiple myeloma patients with renal impairment

Clinical Trials & Observations
Yuan Jian, Long Chang, Ming-Xia Shi, Ying Sun, Xiao-Xia Chu, Hua Xue, Wen-Rong Huang, Xu-Liang Shen, Jie Ma, Guo-Rong Jia, Ya-Qing Feng, Zhen-Fang Xi, Yan-Hong Zhao, Yan-Ping Ma, Jing Xiao, Guang-Yu Ma, Qing-Ming Wang, Li Bao, Yu-Jun Dong, He-Bing Zhou, Chun-Yan Sun, Guo-Hong Su, Yan Yan, Sai-Yin Qimuge, Li-Ping Su, Jing-Nan Sun, Wei-Wei Tian, Xiu-Li Sun, Hong-Mei ing, Da Gao, Wen-Ming Chen, Jian Li, Wen Gao
Journal: Blood Advances
Blood Adv (2023) 7 (24): 7581–7584.
https://doi.org/10.1182/bloodadvances.2023011428
Published: 2023
Includes: Supplemental data
Journal Articles

A risk score for predicting hospitalization for community-acquired pneumonia in ITP using nationally representative data

Clinical Trials & Observations
Ye-Jun Wu, Ming Hou, Hui-Xin Liu, Jun Peng, Liang-Ming Ma, Lin-Hua Yang, Ru Feng, Hui Liu, Yi Liu, Jia Feng, Hong-Yu Zhang, Ze-Ping Zhou, Wen-Sheng Wang, Xu-Liang Shen, Peng Zhao, Hai-Xia Fu, Qiao-Zhu Zeng, Xing-Lin Wang, Qiu-Sha Huang, Yun He, Qian Jiang, Hao Jiang, Jin Lu, Xiang-Yu Zhao, Xiao-Su Zhao, Ying-Jun Chang, Lan-Ping Xu, Yue-Ying Li, Qian-Fei Wang, Xiao-Hui Zhang
Journal: Blood Advances
Blood Adv (2020) 4 (22): 5846–5857.
https://doi.org/10.1182/bloodadvances.2020003074
Published: 2020
Includes: Supplemental data